Bill Sponsor
House Bill 6829
118th Congress(2023-2024)
HEARTS Act of 2024
Active
Active
Passed House on Sep 23, 2024
Overview
Text
Introduced
Dec 14, 2023
Latest Action
Sep 24, 2024
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
6829
Congress
118
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Democrat
New Jersey
Republican
Florida
Democrat
New Jersey
House Votes (1)
Senate Votes (0)
checkPassed on September 23, 2024
Status
Passed
Type
Voice Vote
Voice Vote
A vote in which the presiding officer states the question, then asks those in favor and against to say "Yea" or "Nay," respectively, and announces the result according to his or her judgment. The names or numbers of senators voting on each side are not recorded.
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5573-5574)
Summary

Cardiomyopathy Health Education, Awareness, Research, and Training in the Schools Act of 2023 or the HEARTS Act of 2023

This bill establishes a series of programs and requirements relating to cardiomyopathy. (Cardiomyopathy refers to a collection of diverse conditions of the heart muscle that can affect the ability of the heart to pump blood.)

Specifically, the Department of Health and Human Services must disseminate information about cardiomyopathy and the use of automated external defibrillators to certain school professionals, families, and others, and it must develop specified risk assessment tools for cardiomyopathy. In addition, the Centers for Disease Control and Prevention must report on certain research and surveillance activities, and the National Institutes of Health must report on its research relating to cardiomyopathy.

Text (4)
September 24, 2024
September 23, 2024
May 22, 2024
December 14, 2023
Actions (16)
09/24/2024
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
09/23/2024
Motion to reconsider laid on the table Agreed to without objection.
09/23/2024
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5573-5574)
09/23/2024
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5573-5574)
09/23/2024
DEBATE - The House proceeded with forty minutes of debate on H.R. 6829.
09/23/2024
Considered under suspension of the rules. (consideration: CR H5573-5575)
09/23/2024
Mr. Bucshon moved to suspend the rules and pass the bill, as amended.
05/22/2024
Placed on the Union Calendar, Calendar No. 432.
05/22/2024
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-520.
03/20/2024
Ordered to be Reported (Amended) by the Yeas and Nays: 42 - 0.
03/20/2024
Committee Consideration and Mark-up Session Held
03/12/2024
Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 24 - 0.
03/12/2024
Subcommittee Consideration and Mark-up Session Held
12/15/2023
Referred to the Subcommittee on Health.
12/14/2023
Referred to the House Committee on Energy and Commerce.
12/14/2023
Introduced in House
Graphics
H.R.6829 118 HEARTS Act of 2023
Public Record
Record Updated
Sep 30, 2024 12:56:12 PM